S&P 500   4,350.99 (+0.48%)
DOW   34,121.60 (+0.15%)
QQQ   361.52 (+1.02%)
AAPL   176.79 (+1.64%)
MSFT   319.92 (+0.12%)
META   302.48 (+2.28%)
GOOGL   131.82 (+1.06%)
AMZN   131.10 (+1.37%)
TSLA   254.52 (-0.46%)
NVDA   419.17 (+2.19%)
NIO   8.55 (+1.18%)
BABA   88.51 (+5.23%)
AMD   97.46 (+1.40%)
T   15.17 (-0.91%)
F   12.49 (+2.38%)
MU   69.67 (+2.61%)
CGC   0.84 (+8.97%)
GE   112.64 (-0.31%)
DIS   82.19 (-0.65%)
AMC   8.02 (+4.16%)
PFE   32.65 (-0.61%)
PYPL   58.86 (+0.41%)
NFLX   382.51 (-0.43%)
S&P 500   4,350.99 (+0.48%)
DOW   34,121.60 (+0.15%)
QQQ   361.52 (+1.02%)
AAPL   176.79 (+1.64%)
MSFT   319.92 (+0.12%)
META   302.48 (+2.28%)
GOOGL   131.82 (+1.06%)
AMZN   131.10 (+1.37%)
TSLA   254.52 (-0.46%)
NVDA   419.17 (+2.19%)
NIO   8.55 (+1.18%)
BABA   88.51 (+5.23%)
AMD   97.46 (+1.40%)
T   15.17 (-0.91%)
F   12.49 (+2.38%)
MU   69.67 (+2.61%)
CGC   0.84 (+8.97%)
GE   112.64 (-0.31%)
DIS   82.19 (-0.65%)
AMC   8.02 (+4.16%)
PFE   32.65 (-0.61%)
PYPL   58.86 (+0.41%)
NFLX   382.51 (-0.43%)
S&P 500   4,350.99 (+0.48%)
DOW   34,121.60 (+0.15%)
QQQ   361.52 (+1.02%)
AAPL   176.79 (+1.64%)
MSFT   319.92 (+0.12%)
META   302.48 (+2.28%)
GOOGL   131.82 (+1.06%)
AMZN   131.10 (+1.37%)
TSLA   254.52 (-0.46%)
NVDA   419.17 (+2.19%)
NIO   8.55 (+1.18%)
BABA   88.51 (+5.23%)
AMD   97.46 (+1.40%)
T   15.17 (-0.91%)
F   12.49 (+2.38%)
MU   69.67 (+2.61%)
CGC   0.84 (+8.97%)
GE   112.64 (-0.31%)
DIS   82.19 (-0.65%)
AMC   8.02 (+4.16%)
PFE   32.65 (-0.61%)
PYPL   58.86 (+0.41%)
NFLX   382.51 (-0.43%)
S&P 500   4,350.99 (+0.48%)
DOW   34,121.60 (+0.15%)
QQQ   361.52 (+1.02%)
AAPL   176.79 (+1.64%)
MSFT   319.92 (+0.12%)
META   302.48 (+2.28%)
GOOGL   131.82 (+1.06%)
AMZN   131.10 (+1.37%)
TSLA   254.52 (-0.46%)
NVDA   419.17 (+2.19%)
NIO   8.55 (+1.18%)
BABA   88.51 (+5.23%)
AMD   97.46 (+1.40%)
T   15.17 (-0.91%)
F   12.49 (+2.38%)
MU   69.67 (+2.61%)
CGC   0.84 (+8.97%)
GE   112.64 (-0.31%)
DIS   82.19 (-0.65%)
AMC   8.02 (+4.16%)
PFE   32.65 (-0.61%)
PYPL   58.86 (+0.41%)
NFLX   382.51 (-0.43%)

Canada Goose is Projecting Optimism, but Investors Aren’t Buying

Canada Goose stock price

Key Points

  • Canada Goose delivered a solid earnings report and offered upbeat guidance for the remainder of 2023 with one exception. 
  • The company is forecasting continued weakness in the United States as consumer’s appetite for discretionary purchases appears to be declining. 
  • Barclay’s downgraded GOOS stock prior to the earnings report, but institutional investors are doing more buying than selling. 
  • GOOS stock may be forming a bottom, but investors have time to wait. 
  • 5 stocks we like better than Canada Goose

Canada Goose Holdings, Inc. NYSE: GOOS delivered a solid earnings report on May 18. The maker of premium outerwear beat on both its top and bottom lines. And in a year when what a company says about its future matters more than its current results, Canada Goose projected upbeat guidance. Specifically, the company expects to see continued growth in Asia and Europe. 

In the next quarter, which is the company’s fiscal first quarter, Canada Goose is projecting total revenue of $70 to $80 million and adjusted earnings per share of negative 89 cents to negative 82 cents. It's important to note that this is historically the company's weakest quarter. And the revenue number would be a 30% increase on the low end of the guidance. However, the earnings number at the low end is nearly double the loss in either of the prior two years.  

So why is the stock down over 20% since the report? You can give a nod to the usual suspects of inflation and the continued expectation of a recession at some point this year. And Canada Goose alluded to in its earnings report, particularly when it came to the United States. 

The company issued a cautious outlook for its U.S. business for the remainder of 2023. The company cited macroeconomic issues as a key reason for the 4.5% decline in quarterly U.S. revenue.  

And the rest of the year is not looking much better. According to chief financial officer (CFO) Jonathan Sinclair said, “...the market is going to be a little bit more challenging in the U.S. because of the macroeconomics.” 

Analysts and Investors are Fading GOOS Stock 

According to the Canada Goose analyst ratings from MarketBeat, the stock has a Hold rating with a price target of $20.30. That’s right about where GOOS stock was trading before the earnings report. But recent analyst activity is more bearish.  

On May 6, 2023 – nearly two weeks before Canada Goose reported earnings, the analyst firm Barclay’s downgraded GOOS stock to Equal Weight from Overweight. And following the earnings report, Bank of America NYSE: BAC lowered its price target on the stock from $17 to $14.80.  


The stock also continues to have high short interest with 27% of the stock’s float being sold short. And the short interest ratio which approximates the days short sellers have to cover their positions is over 10 days.  

Institutions Appear to Be Buying

Despite what appears to be negative sentiment for GOOS stock. There does appear to be a bright spot. Institutional investors are still buying the stock. Overall institutional ownership is 42% which is not particularly impressive. However, buyers outnumber sellers by two to one. And in the most recent quarter that ratio was about three to one.  

Since institutional investors are always forward looking, this could indicate that institutional investors are optimistic about the long-term prospect for GOOS stock. But does it mean that retail investors should be buying the dip? 

A Wait-and-See Approach Is Justified 

Trading just above $16 a share as of this writing, GOOS stock is within 10% of its 52-week low. That could make it an attractive target for investors. However, there’s a difference between price and value and Canada Goose has a premium valuation with a price-to-earnings ratio of 33.4x. There’s nothing in the company’s forecast that justifies that premium at this time. 

The company may continue to grow sales in China since the company appears to have no appetite for more lockdowns despite rising Covid-cases. But the index of leading economic indicators continues to scream weakness and that should be enough to make investors hesitant of an overvalued retail stock.  

 

Should you invest $1,000 in Canada Goose right now?

Before you consider Canada Goose, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canada Goose wasn't on the list.

While Canada Goose currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Canada Goose (GOOS)
2.3687 of 5 stars
$14.41-0.4%N/A40.03Hold$30.73
Compare These Stocks  Add These Stocks to My Watchlist 

Chris Markoch

About Chris Markoch

Contributing Author: Retirement, Individual Investing

Chris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.

Contact Chris Markoch via email at CTMarkoch@msn.com.

Featured Articles and Offers

Search Headlines:

My Account -